MedTrace Logo

Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy

NCT04029961 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-05-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy of an immersive virtual reality (VR)-based education program with a form of patient education commonly provided by clinics (e.g., an educational video) at delivering education to breast cancer patients as they prepare for radiation therapy treatment. Self-evaluation questionnaires completed by participants will be used to measure changes in information needs and anxiety, stress, preparedness and satisfaction levels pre/post education between the VR-based education and video education groups in this study. Expanded access to the current VR-based education program will depend on licensing status for associated assets by interested parties.

Conditions

  • Anxiety
  • Stress
  • Satisfaction, Patient
  • Preparedness
  • Information Needs

Interventions

OTHER

Video Education

Prior to their CT simulation, participants will receive education on radiation therapy in the form of a video.

OTHER

VR-based Education

Prior to their CT simulation, participants will receive education on radiation therapy in the form of an immersive VR program delivered through a head-mounted display (HMD).

Sponsors & Collaborators

  • Marquette University

    collaborator OTHER

  • Froedtert Hospital

    collaborator OTHER

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • John LaDisa, PhD · Medical College of Wisconsin

  • Monica Shukla, MD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2020-04-14
Completion
2020-04-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04029961 on ClinicalTrials.gov